Orthofix, AxoGen, and CECO Environmental reported strong Q4 sales and EBITDA growth, with positive 2026 guidance. AdaptHealth and Addus HomeCare highlighted operational improvements and new contracts, while Apellis and Tarsus Pharmaceuticals showcased breakout commercial success for their flagship products.
Comments